297 related articles for article (PubMed ID: 34367253)
1. A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.
Pan X; Bi F
Front Genet; 2021; 12():694009. PubMed ID: 34367253
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
3. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
4. Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer.
Wang J; Zhang X; Zheng F; Yang Q; Bi F
J Ovarian Res; 2023 Aug; 16(1):177. PubMed ID: 37633972
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
6. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.
Peng J; Hao Y; Rao B; Zhang Z
Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Liu N; Liu Z; Liu X; Chen H
Front Oncol; 2019; 9():935. PubMed ID: 31649871
[TBL] [Abstract][Full Text] [Related]
8. Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer.
Zheng J; Guo J; Zhang H; Cao B; Xu G; Zhang Z; Tong J
Front Genet; 2021; 12():672674. PubMed ID: 34367239
[TBL] [Abstract][Full Text] [Related]
9. Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network.
Liang H; Bai Y; Wang H; Yang X
Front Genet; 2020; 11():566497. PubMed ID: 33664764
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer.
Wu W; Gao C; Chen L; Zhang D; Guo S
Oncol Lett; 2021 Dec; 22(6):843. PubMed ID: 34777587
[TBL] [Abstract][Full Text] [Related]
11. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer.
Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M
Front Oncol; 2022; 12():780950. PubMed ID: 35280739
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma.
Zhou S; Fang J; Sun Y; Li H
Front Genet; 2020; 11():934. PubMed ID: 33193574
[TBL] [Abstract][Full Text] [Related]
13. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma.
Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G
Front Genet; 2022; 13():890641. PubMed ID: 35860468
[No Abstract] [Full Text] [Related]
14. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
15. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
16. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
18. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z
Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
Front Genet; 2022; 13():760514. PubMed ID: 35273635
[No Abstract] [Full Text] [Related]
[Next] [New Search]